Quantcast

Latest Amphetamines Stories

2011-02-09 17:46:00

EL CAJON, Calif., Feb. 9, 2011 /PRNewswire/ -- On January 26, 2011, it was reported that 13 University of Iowa football players were affected so severely by rhabdomyolysis that they were hospitalized. Occurrences of rhabdomyolysis--muscle breakdown--are so rare that it suggests an additional causal factor, such as a drug. Drugs known as 'statins,' widely used to lower cholesterol, are known in rare cases to cause rhabdomyolysis. It seems more likely, however, that amphetamines,...

2011-01-11 09:00:00

WASHINGTON D.C. and MINNEAPOLIS, January 11, 2011 /PRNewswire/ -- MDMA (Medical Device Manufacturers Association), the leading national trade association for innovative and entrepreneurial medical technology companies and WMDO (World Medical Device Organization), the leading global provider of innovative online training for medical device professionals, announced today a business alliance that offers MDMA Members complete access to WMDO's extensive catalogue of professional online...

2011-01-03 08:21:33

(Ivanhoe Newswire) "“ Amphetamines are drugs known as stimulants, and are commonly abused in the U.S. This study shows that the amount of alcohol consumed may increase the likelihood of developing drug abuse, which can be used in helping to understand treatment challenges. Stimulant drugs, which can increase energy and concentration, are widely abused by young adults. One such drug are amphetamines, which in addition to being widely accessible, has been shown in previous studies to have...

1cd74c7412072240dce386e529751fce1
2010-12-15 11:11:17

Ecstasy produces loving feelings and alters perception of others MDMA or 'ecstasy' increases feelings of empathy and social connection. These 'empathogenic' effects suggest that MDMA might be useful to enhance the psychotherapy of people who struggle to feel connected to others, as may occur in association with autism, schizophrenia, or antisocial personality disorder. However, these effects have been difficult to measure objectively, and there has been limited research in humans. Now,...

2010-12-15 00:30:46

New research indicates that ingesting moderate amounts of alcohol may increase an individual's risk of amphetamine abuse     * Amphetamines are part of a large group of drugs known as stimulants, which are commonly misused in the United States    * A new study shows that the amount of alcohol consumed may increase the likelihood of developing drug abuse    * These results indicate that there is a possible link between drinking and other drug abuse,...

2010-12-06 07:00:00

BURLINGTON, Mass., Dec. 6, 2010 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the attention-deficit/hyperactivity disorder (ADHD) drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan will fluctuate modestly over the next decade, decreasing from $5 billion in 2009 to a trough in 2013 before climbing to $4.1 billion in 2019. An expanding drug-treated...

2010-11-15 08:15:00

PHILADELPHIA, Nov. 15, 2010 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the prescription medication Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents ages 13 to 17. The approval is based on study data demonstrating that Vyvanse improved ADHD symptoms...

2010-11-10 06:00:00

PHILADELPHIA, November 10, 2010 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that the U.S. Court of Appeals for the District of Columbia Circuit has affirmed the ruling of the U.S. District Court for the District of Columbia and the U.S. Food and Drug Administration to grant five-year New Chemical Entity exclusivity to lisdexamfetamine dimesylate, currently marketed by Shire U.S. Inc. under the name VYVANSE(R)....

2010-11-04 12:20:00

BURLINGTON, Mass., Nov. 4, 2010 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the majority of surveyed primary care physicians (PCPs) and endocrinologists indicate that--if these therapies are approved for obesity--they will prescribe Orexigen Therapeutics/Takeda's Contrave (a fixed dose combination of naltrexone and bupropion), Arena Pharmaceuticals/Eisai's Lorqess (lorcaserin) and Vivus's...

2010-10-29 05:45:00

PHILADELPHIA, October 29, 2010 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced results from a Phase 2 signal finding study of Vyvanse(R) [lisdexamfetamine dimesylate (or SPD489)] in patients who have had residual symptoms of depression following treatment with LEXAPRO(R) (escitlopram) for Major Depressive Disorder (MDD). Based on these findings, Shire intends to advance discussions with regulators to explore...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.